BML (4694) Q3 2024 earnings summary

Executive summary

• Net sales for the first nine months of FY2024 rose 3.2% year-over-year to ¥108,579 million, with operating profit up 5.2% to ¥8,142 million and profit attributable to owners of parent up 1.0% to ¥5,260 million.

• Growth was driven by solid non-COVID-19 testing demand and profitability initiatives, despite a decrease in COVID-19-related testing and continued competitive pressures.

Financial highlights

• Gross profit increased to ¥35,719 million from ¥35,243 million year-over-year, while operating profit rose to ¥8,142 million from ¥7,737 million.

• Ordinary profit reached ¥8,444 million, up from ¥8,097 million, and basic earnings per share increased to ¥134.91 from ¥133.66.

• Total assets as of December 31, 2024, were ¥173,867 million, up ¥2,875 million from March 31, 2024.

• Net assets increased to ¥131,975 million, with an equity ratio of 73.4%.

Outlook and guidance

• Full-year FY2024 net sales are forecast at ¥140,000 million (up 1.5% year-over-year), with operating profit of ¥9,200 million and profit attributable to owners of parent of ¥6,100 million.

• No changes have been made to previously announced full-year forecasts.